c0h9a2h5g This drug is a complement to diet and exercise that aids obesity and overweight patients who suffer from Type 2 diabetes and has abnormal levels of fat in the blood. acomplia drug This drug is a first new class therapeutic agents called Cannabinoid-1 Receptor blocker that treats obesity and related conditions. It was October 2008, where European Medicines Agency concluded that benefits of Acomplia no longer outweighed its risks and it is recommended to be withdrawed in the market.
